B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 1.86 EUR 2.2% Market Closed
Market Cap: 37.8m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Wall Street
Price Targets

BRETEC Price Targets Summary
Bioretec Oy

Wall Street analysts forecast BRETEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.45 EUR with a low forecast of 2.42 EUR and a high forecast of 2.52 EUR.

Lowest
Price Target
2.42 EUR
30% Upside
Average
Price Target
2.45 EUR
32% Upside
Highest
Price Target
2.52 EUR
35% Upside
Bioretec Oy Competitors:
Price Targets
IPD
ImpediMed Ltd
169% Upside
6869
Sysmex Corp
3% Upside
099190
I Sens Inc
80% Upside
PRN
Profound Medical Corp
73% Upside
IRMD
IRadimed Corp
15% Upside
MOVE
Medacta Group SA
30% Upside
NVST
Envista Holdings Corp
2% Upside
DEMANT
Demant A/S
15% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 70%.

22%
Past Growth
70%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRETEC's stock price target?
Price Target
2.45 EUR

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.45 EUR with a low forecast of 2.42 EUR and a high forecast of 2.52 EUR.

What is Bioretec Oy's Revenue forecast?
Projected CAGR
70%

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 70%.

Back to Top